Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Technetium-99m labeled myocardial perfusion imaging agents.

D Jain1

  • 1Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.

Seminars in Nuclear Medicine
|August 5, 1999
PubMed
Summary

Technetium-99m (99mTc) tracers enhance noninvasive diagnosis of coronary artery disease. Myocardial perfusion imaging offers powerful prognostic data, improving patient risk stratification beyond invasive methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Research Letter: Childhood Adversity and Risk of Subsequent Head and Neck Injury: an ABCD Cohort Analysis.

medRxiv : the preprint server for health sciences·2025
Same author

The effect of preoperative carbohydrate loading on patients' anxiety prior to elective caesarean delivery: a randomized controlled trial.

International journal of obstetric anesthesia·2025
Same author

Sex Differences Across Concussion Characteristics in US Service Academy Cadets: A CARE Consortium Study.

Sports medicine (Auckland, N.Z.)·2024
Same author

Non-inferiority randomized controlled trial comparing CricOid pressure and para-laryngeal pressure in parturients undergoing cesarean delivery: NiCOP trial.

International journal of obstetric anesthesia·2024
Same author

CT coronary angiography as an alternative imaging method to ascertain cardiac output and its correlation with echocardiography.

Clinical radiology·2023
Same author

A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG).

Medical oncology (Northwood, London, England)·2023

Area of Science:

  • Nuclear medicine
  • Cardiology
  • Diagnostic imaging

Background:

  • 99mTc labeled myocardial perfusion tracers are crucial for noninvasive diagnosis.
  • These tracers provide comprehensive myocardial perfusion and function data in a single study.
  • They aid in risk stratification for patients with coronary artery disease.

Purpose of the Study:

  • To highlight the advancements in noninvasive diagnostic evaluation using 99mTc tracers.
  • To emphasize the prognostic value of myocardial perfusion imaging.
  • To identify future research directions for improved perfusion tracers and imaging techniques.

Main Methods:

  • Utilizes 99mTc labeled tracers for myocardial perfusion imaging.
  • Integrates myocardial function assessment within the same study.

Related Experiment Videos

  • Compares prognostic information with invasive evaluation methods.
  • Main Results:

    • Myocardial perfusion imaging provides the most powerful prognostic information.
    • This information is incremental to data from invasive evaluations.
    • 99mTc tracers significantly advance diagnostic capabilities.

    Conclusions:

    • 99mTc myocardial perfusion imaging is a powerful tool for risk stratification.
    • Future tracers should linearly track blood flow with minimal splanchnic uptake.
    • Improved attenuation and scatter correction are needed to overcome current limitations.